VALIANT LABORATORIES LTD Intrinsic Value
VALIANTLAB · Healthcare · Current price ₹63.44
Is VALIANT LABORATORIES LTD undervalued?
DocStoX estimates the fair value of VALIANT LABORATORIES LTD at ₹32 per share, versus the current market price of ₹63. That puts the stock about -49.6% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 1 independent method: Residual income (₹32). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹27 (bear) to ₹32 (base) to ₹37 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹63 versus an intrinsic value of ₹32, VALIANT LABORATORIES LTD currently offers -49.6% of negative margin (i.e. a premium).
More on VALIANT LABORATORIES LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.